Tirzepatide in Type 1 Diabetes, with Viral Shah, MD

from Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives · host Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives

In this episode, hosts are joined by Shah for a discussion on his recent proof-of-concept study looking at tirzepatide in type 1 diabetes, the prospect of GLP-1 RA-based therapies in type 1 diabetes, and the potential roles for tirzepatide beyond T2D and weight management.Episode Highlights00:00 - Intro01:56 - Use of GLP-1s in T1D05:32 - Study on Tirzepatide in T1D 10:04 - Insulin Use in Study11:20 - Safety Outcomes

Episode metadata supplied by the publisher feed · Published Feb 15, 2024

Embed this episode

Attribution link and audio player

NOW PLAYING

Tirzepatide in Type 1 Diabetes, with Viral Shah, MD

0:00 16:43

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives?

This episode is 16 minutes long.

When was this Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives episode published?

This episode was published on February 15, 2024.

Can I download this Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!